missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CD42b/GPIb alpha Antibody, R&D Systems™
Mouse Monoclonal Antibody
Marca: R&D Systems MAB4067
473.45 EUR valido fino al 2025-12-16
MIGLIOR PREZZO in promozione! Usa il codice promo "24090" per avere il tuo prezzo promozionale.
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
CD42b/GPIb alpha Monoclonal specifically detects CD42b/GPIb alpha in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.
Specifica
| CD42b/GPIb alpha | |
| Monoclonal | |
| LYOPH | |
| Western Blot 2 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
| P07359 | |
| GP1BA | |
| Mouse myeloma cell line NS0-derived recombinant human CD42b/GPIb alpha His17-Leu505 Accession # P07359 | |
| 100 μg | |
| Primary | |
| Detects human CD42b/GPIb alpha in direct ELISAs and Western blots. | |
| Human | |
| Purified |
| Western Blot, Flow Cytometry, CyTOF | |
| 486805 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Antigen CD42b-alpha, BP1BA, BSS, CD42b, CD42b antigen, CD42b-alpha, glycoprotein Ib (platelet), alpha polypeptide, Glycoprotein Ibalpha, GP1B, GP1BA, GPIb alpha, GP-Ib alpha, GPIbA, GPIb-alpha, MGC34595, platelet glycoprotein Ib alpha chain, platelet membrane glycoprotein 1b-alpha subunit | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 2811 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto